Cargando…

Immunophenotypic characterisation of morphologically diagnosed cases of Acute Myeloid Leukaemia (AML)

OBJECTIVE: To determine immunophenotypic pattern in newly diagnosed cases of acute myeloid leukaemia by flow cytometry and its correlation with morphological findings. METHODS: This study was conducted at Haematology (Pathology) department, Army Medical College, in collaboration with Immunology Depa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Basharat, Maria, Khan, Saleem Ahmed, din, Nasir ud, Ahmed, Dawood
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Professional Medical Publications 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500804/ https://www.ncbi.nlm.nih.gov/pubmed/31086535 http://dx.doi.org/10.12669/pjms.35.2.614

Ejemplares similares

Sweet’s Syndrome (SS) in the Course of Acute Myeloid Leukaemia (AML)
por: Guarneri, Claudio, et al.
Publicado: (2018)

Standardised immunophenotypic analysis of myeloperoxidase in acute leukaemia
por: Bras, Anne E., et al.
Publicado: (2020)

Transcriptomic and proteomic analysis of mouse radiation-induced acute myeloid leukaemia (AML)
por: Badie, Christophe, et al.
Publicado: (2016)

PU.1 downregulation in murine radiation-induced acute myeloid leukaemia (AML): from molecular mechanism to human AML
por: Verbiest, Tom, et al.
Publicado: (2015)

The epidemiology, treatment patterns, healthcare utilizations and costs of Acute Myeloid Leukaemia (AML) in Taiwan
por: Huang, Huai-Hsuan, et al.
Publicado: (2022)

Characterising experiences with acute myeloid leukaemia using an Instagram content analysis
por: Parker, Catriona, et al.
Publicado: (2021)

Burkitt leukaemia with B‐cell precursor immunophenotype
por: Xu, Ke, et al.
Publicado: (2022)

Acute Myeloid Leukemia with RAM Immunophenotype: A Pediatric Case with Unusual Morphologic Features
por: Conces, Miriam, et al.
Publicado: (2017)

Space-time clustering analyses of childhood acute lymphoblastic leukaemia by immunophenotype
por: McNally, R J Q, et al.
Publicado: (2002)

Distribution of subtypes and immunophenotypic characterization of 1379 cases of paediatric acute leukaemia
por: Jamal, Saba, et al.
Publicado: (2021)

Clinico-Haematologic association and prognostic relevance of NPM1 and FLT3-ITD mutations in acute Myeloid Leukaemia
por: Mahmood, Rafia, et al.
Publicado: (2019)

Targeting SAMHD1 with hydroxyurea in first‐line cytarabine‐based therapy of newly diagnosed acute myeloid leukaemia: Results from the HEAT‐AML trial
por: Jädersten, Martin, et al.
Publicado: (2022)

Characterisation of the GRAF gene promoter and its methylation in patients with acute myeloid leukaemia and myelodysplastic syndrome
por: Bojesen, S E, et al.
Publicado: (2006)

Acute Myeloid Leukaemia in Its Niche: the Bone Marrow Microenvironment in Acute Myeloid Leukaemia
por: Ladikou, E. E., et al.
Publicado: (2020)

Immunophenotype and molecular characterisation of adenocarcinoma of the small intestine
por: Overman, M J, et al.
Publicado: (2010)

Co‐diagnoses of acute myeloid leukaemia and COVID‐19: presentation and management implications
por: O'Brien, Amy, et al.
Publicado: (2020)

Prognostic markers in Chronic Lymphocytic Leukaemia - A flow cytometric analysis
por: Haq, Hala, et al.
Publicado: (2020)

Profile of Glasdegib for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML): Evidence to Date
por: Iyer, Sunil Girish, et al.
Publicado: (2022)

A case of chronic myeloid leukaemia presenting as megakaryocytic blast crisis (AML M7)
por: Karkuzhali, Ponnuswamy, et al.
Publicado: (2013)

Antigenic Targets for the Immunotherapy of Acute Myeloid Leukaemia
por: Khan, Ghazala Naz, et al.
Publicado: (2019)

Genetic diversity within leukemia-associated immunophenotype-defined subclones in AML
por: Tiso, F., et al.
Publicado: (2022)

Psychotropic Drug Use in Acute Myeloid Leukaemia (AML) and Myelodysplastic Syndrome (MDS): A Danish Nationwide Matched Cohort Study of 2404 AML and 1307 MDS Patients
por: Jensen, Oda, et al.
Publicado: (2022)

A case of acute megakaryoblastic leukaemia (FAB M7), a rare type of acute myeloid leukemia (AML), in a teenager
por: Olatunji, Philip O, et al.
Publicado: (2018)

Detailed molecular characterisation of acute myeloid leukaemia with a normal karyotype using targeted DNA capture
por: Conte, N, et al.
Publicado: (2013)

Immunophenotypic evolution of blast populations in pediatric acute myeloid leukemia
por: Pereira, Welbert Oliveira, et al.
Publicado: (2016)

Cost-effectiveness analysis of gemtuzumab ozogamicin for the treatment of de novo CD33-positive Acute Myeloid Leukaemia (AML) in Italy
por: Cairoli, Roberto, et al.
Publicado: (2023)

Prognostics and Clinical Outcomes in Patients Diagnosed With Acute Myeloid Leukemia (AML) in a Teaching Hospital
por: Alsulami, Hind A, et al.
Publicado: (2021)

Association between Immunophenotypic Parameters and Molecular Alterations in Acute Myeloid Leukemia
por: Pessoa, Flávia Melo Cunha de Pinho, et al.
Publicado: (2023)

The rocky road to personalized medicine in acute myeloid leukaemia
por: Brinda, Bryan, et al.
Publicado: (2018)

Polypharmacy-Induced Long QT Syndrome in a Patient With Newly Diagnosed Acute Myeloid Leukaemia: A Case Report
por: Khan, Zahid
Publicado: (2023)

Targeting apoptosis in acute myeloid leukaemia
por: Cassier, Philippe A, et al.
Publicado: (2017)

Adhesion Deregulation in Acute Myeloid Leukaemia
por: Gruszka, Alicja M., et al.
Publicado: (2019)

Murine Models of Acute Myeloid Leukaemia
por: Almosailleakh, Marwa, et al.
Publicado: (2019)

Wnt Signalling in Acute Myeloid Leukaemia
por: Gruszka, Alicja M., et al.
Publicado: (2019)

Chromosomal rearrangements in acute myeloid leukemia (AML)
por: Belloni, E, et al.
Publicado: (2010)

New agents in acute myeloid leukemia (AML)
por: Park, Silvia, et al.
Publicado: (2020)

AngioCRIME in Acute Myeloid Leukemia (AML)
por: Macintyre, Elizabeth
Publicado: (2017)

S131: A RANDOMISED ASSESSMENT OF THE SEQUENTIAL ADDITION OF THE KINASE INHIBITOR QUIZARTINIB TO INTENSIVE CHEMOTHERAPY IN OLDER ACUTE MYELOID LEUKAEMIA (AML) PATIENTS: RESULTS FROM THE NCRI AML18 TRIAL
por: Knapper, Steven, et al.
Publicado: (2023)

Analysis of the interaction of induction regimens with p-glycoprotein expression in patients with acute myeloid leukaemia: results from the MRC AML15 trial
por: Pallis, M, et al.
Publicado: (2011)

IL-8 as mediator in the microenvironment-leukaemia network in acute myeloid leukaemia
por: Kuett, Alexander, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_5pq2357k2m3sjkg71a3lr9ko8g